Release Date: 15/09/22 08:17 Summary: Share Divestment (GL1) Price Sensitive: Yes Download Document 94.52KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%